Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    BioVie Inc.

    NASDAQ: BIVI · Real-Time Price · USD
    1.13
    -0.06 (-5.04%)
    At close: Jun 13, 2025, 3:59 PM
    1.12
    -0.88%
    After-hours: Jun 13, 2025, 07:58 PM EDT

    BioVie Statistics

    Share Statistics

    BioVie has 18.57M shares outstanding. The number of shares has increased by -69.83% in one year.

    Shares Outstanding

    n/a
    		 18.57M

    Shares Change (YoY)

    n/a
    		 -69.83%

    Shares Change (QoQ)

    n/a
    		 3.85%

    Owned by Institutions (%)

    n/a
    		 4.71%

    Shares Floating

    n/a
    		 16.15M

    Failed to Deliver (FTD) Shares

    n/a
    		 719

    FTD / Avg. Volume

    n/a
    		 0.17%

    Short Selling Information

    The latest short interest is 1.45M, so 7.8% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.45M

    Short % of Shares Out

    n/a
    		 7.8%

    Short % of Float

    n/a
    		 8.97%

    Short Ratio (days to cover)

    n/a
    		 6.1

    Valuation Ratios

    The PE ratio is -1.17 and the forward PE ratio is -0.8. BioVie's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.17

    Forward PE

    n/a
    		 -0.8

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 2.43

    P/FCF Ratio

    n/a
    		 -1.35

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for BioVie.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.39.

    Current Ratio

    n/a
    		 2.57

    Quick Ratio

    n/a
    		 2.57

    Debt / Equity

    n/a
    		 0.39

    Debt / EBITDA

    n/a
    		 -0.19

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 -11.12

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,294,357.14

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -75.43% in the last 52 weeks. The beta is 1.15, so BioVie's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.15

    52-Week Price Change

    n/a
    		 -75.43%

    50-Day Moving Average

    n/a
    		 0.98

    200-Day Moving Average

    n/a
    		 1.8

    Relative Strength Index (RSI)

    n/a
    		 56.7

    Average Volume (20 Days)

    n/a
    		 420,633

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -229K

    Operating Income

    n/a
    		 -32.18M

    Net Income

    n/a
    		 -32.12M

    EBITDA

    n/a
    		 -31.95M

    EBIT

    n/a
    		 -32.18M

    Earnings Per Share (EPS)

    n/a
    		 -3.55
    Full Income Statement

    Balance Sheet

    The company has 23.84M in cash and 6.11M in debt, giving a net cash position of 17.73M.

    Cash & Cash Equivalents

    n/a
    		 23.84M

    Total Debt

    n/a
    		 6.11M

    Net Cash

    n/a
    		 17.73M

    Retained Earnings

    n/a
    		 -334.23M

    Total Assets

    n/a
    		 24.66M

    Working Capital

    n/a
    		 21.17M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -27.95M and capital expenditures 0, giving a free cash flow of -27.95M.

    Operating Cash Flow

    n/a
    		 -27.95M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -27.95M

    FCF Per Share

    n/a
    		 -3.09
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    BIVI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BIVI is $30, which is 2554.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $30

    Price Target Difference

    n/a
    		 2554.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 6, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Aug 6, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -17.19

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist